期刊文献+

内脂素促进巨噬细胞向致血栓表型转化 被引量:1

Visfatin Promoted Macrophages Conversion to a Thrombogenic Phenotype Independent of Insulin Receptor Signalling
下载PDF
导出
摘要 目的研究内脂素对巨噬细胞中组织因子(TF)和纤溶酶原激活物抑制剂-1(PAI-1)表达的影响及可能的机制。方法体外培养的THP-1细胞中加入不同浓度的内脂素(包括空白对照,50ng/ml,100ng/ml三个浓度组),每组分别孵育6小时,12小时和24小时各3个时间点。同时设立2-羟基萘甲基磷酸三乙酸甲基酯(HNMPA;100umol/L)组。将各组细胞进行realtime PCR和Western blot检测,比较各组TF和PAI-1表达的情况。结果内脂素增加巨噬细胞中TF和PAI-1的mRNA转录和蛋白质表达水平,HNMPA不影响内脂素的这些效应。结论内脂素促进巨噬细胞向促血栓表型转化,机制与胰岛素受体相关的途径无关。 Objective To investigate effects of visfatin on expression of TF and PAI-1 in macrophages and related mechanism.Methods We treated THP-1-derived macrophages with visfatin ranged from 0 to100ng/ml for 6 to 24 hours,and tested mRNA expression and protein production of TF and PAI-1 by realtime quantified-PCR and Western blot analysis respectively.By administering HNMPA-an insulin receptor antagonist,we intended to determine whether visfatin influence TF and PAI-1 expressions through insulin receptor signalling.Results We showed that visfatin enhanced mRNA expression and protein production of TF and PAI-1 in macrophages(p<0.05),and HNMPA did not inhibit these effects.Conclusion We demonstrated that visfatin could promote macrophages conversion to a thrombogenic phenotype independent of insulin receptor signalling,which might be one of mechanisms underlying plaque vulnerability in atherosclerosis.
出处 《中国分子心脏病学杂志》 CAS 2010年第6期356-359,共4页 Molecular Cardiology of China
关键词 内脂素 巨噬细胞 血栓形成 动脉粥样硬化 Visfatin Macrophage Thrombosis Atherosclerosis
  • 相关文献

参考文献21

  • 1Radu C. Oita,Dudley Ferdinando,Steve Wilson,Christopher Bunce,Dawn J. Mazzatti.Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NF?B-dependent manner[J]. Pflügers Archiv - European Journal of Physiology . 2010 (4)
  • 2T. Romacho,V. Azcutia,M. Vázquez-Bella,N. Matesanz,E. Cercas,J. Nevado,R. Carraro,L. Rodríguez-Ma?as,C. F. Sánchez-Ferrer,C. Peiró.Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity[J]. Diabetologia . 2009 (11)
  • 3Kang YS,Song HK,Lee,MH,et al.Visfatin is upregulated in type-2diabetic rats and targets renal cells. Kidney International . 2010
  • 4Yu XY,Qiao SB,Guan HS,et al.Effects of Visfatin on Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts. Hormone and Metabolic Research . 2010
  • 5Brown JEP,Onyango DJ,Ramanjaneya M,et al.Visfatin regulates insulin secretion,insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells. Journal of Molecular Endocrinology . 2010
  • 6Chomiki N,Henry M,Alessi MC,et al.Plasminogen activator inhibitor 1 expression in human liver and healthy or atherosclerotic vessel walls. Thrombosis and Haemostasis . 1994
  • 7Scholz H,Sandberg W,Damas JK,et al.Enhanced plasma levels ofLIGHTin unstable angina:possible pathogenic role in foam cell formationand thrombosis. Circulation . 2005
  • 8Jia SH,Li Y,Parodo J,et al.Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation, The . 2004
  • 9Moschen AR,Kaser A,Enrich B,et al.Visfatin,an adipocytokine with proinflammatory and immunomodulating properties. The Journal of Immunology . 2007
  • 10Virmani R,Burke AP,Farb A,et al.Pathology of the unstable plaque. Progress in Cardiology . 2002

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部